PCML
REPL icon

Pavaki Capital Management LLC’s Replimune Group REPL Stock Holding History

Pavaki Capital Management LLC’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$890K Buy
+80,400
New +$492K 0.31% 58

Other funds holding REPL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Pavaki Capital Management LLC's REPL Position: Q2 2026 in Review

Pavaki Capital Management LLC opened a new position in Replimune Group (REPL) in Q2 2026: 80,400 shares worth $890K. The stake represents 0.31% of the portfolio and ranks #58 among its holdings.

70 funds tracked by Wall St. Rank hold REPL as of Q2 2026.

  • Pavaki Capital Management LLC held 80,400 shares of Replimune Group worth $890K as of Q2 2026.
  • Replimune Group was a new Pavaki Capital Management LLC position in Q2 2026.
  • Replimune Group made up 0.31% of Pavaki Capital Management LLC's portfolio in Q2 2026, its #58 holding.
  • 70 funds tracked by Wall St. Rank held Replimune Group as of Q2 2026.

Based on Pavaki Capital Management LLC's 13F filing for Q2 2026, filed 7 Aug 2026.